Podcast with Prof. Véronique Leblond about a phase II study exploring the “chemo-free” treatment association of idelalisib and obinutuzumab in relapsed or refractory WM
Ariez Publishing
Podcast with Prof. Véronique Leblond about a phase II study exploring the “chemo-free” treatment association of idelalisib and obinutuzumab in relapsed or refractory WM
00:00 / 05:54